Published by Josh White on 1st May 2026
(Sharecast News) - Shield Therapeutics reported first-quarter net revenue of $18m and positive EBIT on Friday, helped by a China milestone payment and continued growth in US sales of its iron deficiency treatment ACCRUFeR.
URL: http://www.digitallook.com/dl/news/story/35905604/...